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Abstract Chronic granulomatous disease (CGD) is a rare
inherited disorder in which phagocytes lack NADPH
oxidase activity. The most common form is caused by
mutations in the CYBB gene encoding gp91phox protein,
the heavy chain of cytochrome b558, which is the redox
element of NADPH oxidase. In some rare cases, the
mutated gp91phox is normally expressed but no NADPH
oxidase can be detected. This type of CGD is called X91+
CGD. We have previously reported an X+ CGD case with
a double-missense mutation in gp91phox. Transgenic
PLB-985 cells have now been made to study the impact
of each single mutation on oxidase activity and assembly
to rule out a possible new polymorphism in the CYBB
gene. The His303Asn/Pro304Arg gp91phox transgenic
PLB-985 cells exactly mimic the phenotype of the
neutrophils of the X+ CGD patient. The His303Asn
mutation is sufficient to inhibit oxidase activity in intact
cells and in a broken cell system, whereas in the
Pro304Arg mutant, residual activity suggests that the
Pro304Arg substitution is less devastating to oxidase
activity than the His303Asn mutation. The study of
NADPH oxidase assembly following the in vitro and in
vivo translocation of cytosolic factors p47phox and
p67phox has demonstrated that, in the double mutant
and in the His303Asn mutant, NADPH oxidase assembly
is abolished, although the translocation is only attenuated
in Pro304Arg mutant cells. Thus, even though the
His303Asn mutation has a more severe inhibitory effect
on NADPH oxidase activity and assembly than the
Pro304Arg mutation, neither mutation can be considered
as a polymorphism.
Introduction
The dysfunction of NADPH oxidase in phagocytes results
in a severe orphan genetic disease, chronic granulomatous
disease (CGD). Patients with CGD suffer from recurrent,
often life-threatening, bacterial and fungal infections
because of the absence of a superoxide anion ðO2 Þ -
generating system (Winkelstein et al. 2000). NADPH
oxidase is a multi-component complex composed of
membrane-bound cytochrome b558, the cytosolic proteins
p67phox, p47phox, p40phox and two small GTPases,
Rac2 and Rap1A. Cytochrome b558, the redox center of
the NADPH oxidase complex, is a heterodimer consisting
of a large flavocytochrome gp91phox (or β sub-unit or
Nox2) and a small protein p22phox (or α sub-unit). In
resting cells, cytosolic and membrane-bound components
of the NADPH oxidase complex are dissociated. During
the activation of phagocytotic cells by several activators,
such as the C5a complement fragment, cytokines, chemo-
tactic peptides, opsonized bacteria or fungi, the NADPH
oxidase complex becomes assembled and the activated
enzyme can produce bactericidal O2 (Vignais 2002).
The three types of autosomal CGD exhibit mutations in
the genes encoding the p47phox, p67phox and p22phox
proteins, whereas the most common X-linked CGD type
(approximately 60%) has defects in the CYBB gene
encoding gp91phox in which cytochrome b558 is absent
(X910; Segal et al. 2000). The CYBB gene (GenBank
accession no. X04011) was one of the first to be identified
by positional cloning (Royer-Pokora et al. 1986), follow-
ing chromosomal localization to Xp21.1 (Baehner et al.
1986). It encompasses 13 exons spanning about 30 kb
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genomic DNA (Skalnik et al. 1991). In the majority of X-
linked CGD cases, mutations, including deletions, inser-
tions, splice site, missense and nonsense mutations, lead to
an unstable gp91phox protein with either absent or
markedly reduced expression (Roos et al. 1996). The
CYBB gene appears to be extremely sensitive to mutations
because only one polymorphism within the coding region
has been discovered (Kuribayashi et al. 1996). In a few
rare cases, missense mutations resulting in normal levels
of nonfunctional cytochrome b558 have been identified
(X91+; for a review, see Heyworth et al. 2003). Some of
these have provided interesting information about the
structure of NADPH oxidase and its activation mechan-
isms (Cross et al. 1995; Leusen et al. 1994, 2000). An in
vitro cellular model of X-CGD has been developed (Zhen
et al. 1993). The X chromosome-linked CGD locus is
disrupted by homologous recombination in the PLB-985
human myeloïd cell line (X-CGD PLB-985 cells). Only
one functional analysis of an X+ CGD case has been
studied in these transgenic cells (Yu et al. 1999). An X+
CGD patient with a double mutation (C919A and C923G,
leading to His303Asn/Pro304Arg substitution) close to the
putative flavin adenine dinucleotide (FAD)-binding site in
gp91phox has been previously reported (Stasia et al.
2002). However, FAD binding is normal but NADPH
oxidase assembly is strongly inhibited during the in vitro
activation process. A double-mutation is a rare event in
genetic diseases and determination of the real disease-
causing mutation is generally difficult, especially in the
case of a missense type. Generally, a single base change is
sufficient to provoke the disease. Only one double
missense mutation has been reported in the NCF2 gene
encoding p67phox resulting in CGD disease (Bonizzato et
al. 1997).
In the present study, we stably transfected the
His303Asn, the Pro304Arg or the double substitution
gp91phox cDNA into X-CGD PLB-985 cells to create cell
lines expressing the first, second or double-gp91phox
mutation. The control cell line was the X-CGD PLB-985
cells transfected with the wild-type (WT) gp91phox cDNA
(WT gp91phox cDNA PLB-985 cells) in which the
NADPH oxidase was totally restored. The aim was
carefully to dissect the impact of each mutation and the
double mutation on gp91phox expression and on the
activity and assembly of NADPH oxidase and to rule out
the eventuality of a new polymorphism in the CYBB gene.
Gene symbols used in this article follow the recom-
mendations of the HUGO Gene Nomenclature Committee
(Povey et al. 2001)
Materials and methods
Construction of transgenic PLB-985 cell lines
His303Asn, Pro304Arg and the double mutation were
generated from the WT gp91phox cDNA in pBlue-
ScriptKS(+) vector by site-directed mutagenesis (Quik
change site-directed mutagenesis kit, Stratagene, La Jolla,
Calif., USA). The WT and the mutated gp91phox cDNA
were sub-cloned into the BamH1 site of the mammalian
expression vector pEF-PGKneo (a generous gift from Dr.
M. C. Dinauer). The insertion sense and the gp91phox
cDNA sequence mutation were verified by sequencing
(Genome Express, Grenoble, France) on the Abi Prism
automatic sequencer (Perkin Elmer, Courtaboeuf, France).
All the gp91phox cDNA constructs were transfected into
X-CGD PLB-985 cells (provided by Dr. M. C. Dinauer)
by electroporation at 250 V (one pulse of 20 ms). Positive
clones were selected by limited dilution in the presence of
1.5 mg/ml Geneticin.
Cell culture and granulocyte differentiation
Wild-type, X-CGD and transfected PLB-985 cells (ex-
pressing WT or the mutant gp91phox in His303Asn,
Pro304Arg or double mutants) were maintained in RPMI-
1640 supplemented with 10% (vol/vol) fetal calf serum,
100 U/ml penicillin, 50 μg/ml streptomycin, 2 mM L-
glutamine at 37°C in a 5% CO2 atmosphere. In transgenic
PLB-985 cells after selection, 0.5 mg/ml Geneticin was
added to maintain the selection pressure. To induce
differentiation and expression of endogenous NADPH
oxidase components, cells were differentiated for 6 days
with 0.5% (vol/vol) dimethylformamide (DMF; Tucker et
al. 1987). The WT PLB-985 cells are the original WT
PLB-985 cells; the X-CGD PLB-985 cells are WT PLB-
985 cells in which the CYBB gene had been knock-out; the
WT gp91phox PLB-985 cells were X-CGD PLB-985 cells
transfected with WT gp91phox cDNA; the His303Asn or
Pro304Arg or His303Asn/Pro304Arg gp91phox PLB-985
cells were X-CGD PLB-985 cells transfected with the
His303Asn or Pro304Arg or His303Asn/Pro304Arg
mutated gp91phox cDNA.
Assessment of gp91phox protein expression by flow
cytometry
Gp91phox expression in transgenic and WT PLB-985 cells
was assessed by using monoclonal antibodies (mAbs)
directed against an external epitope of gp91phox (7D5;
Yamauchi et al. 2001) or control monoclonal IgG1
(Immunotech, Marseille, France) as described in Stasia
et al. (2003). Results are expressed as mean fluorescence
intensity (MFI) values in arbitrary units (au). All
experiments were performed in triplicate.
Chemiluminescent detection of H2O2 production
H2O2 production of intact granulocyte-differentiated cells
(5×105 cells) in phosphate-buffered saline (PBS) contain-
ing 20 mM glucose, 10 U/ml horseradish peroxidase,
0.02 mM luminol were stimulated with 80 ng/ml phorbol
myristate acetate (PMA; Dahlgren and Karlsson 1999).
Relative luminescence unit (RLU) counts monitored at
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37°C were estimated in a Luminoscan luminometer
(Labsystems, Helsinki, Finland) coupled to a computer.
Cytochrome b558 spectroscopy
Purified neutrophils treated with 3 mM diisopropyl
fluorophosphate were lysed for cytochrome b558 extrac-
tion. The supernatant was used for the immunoblotting
experiment and cytochrome b558 spectroscopy. Reduced
minus oxidized differential absorption spectra were
recorded at room temperature on a DU 640 Beckman
spectrophotometer (Batot et al. 1998).
SDS-polyacrylamide gel electrophoresis and
immunoblotting
Proteins solubilized in a 1% Triton X100 from neutrophils
were separated by SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) in 10% (wt/vol) acrylamide gel with a 5%
(wt/vol) stacking gel (Laemmli 1970), electrotransferred to
nitrocellulose (Towbin et al. 1979), and immunodetected
by mAbs 449 and 48 directed against p22phox and
gp91phox, respectively (Verhoeven et al. 1989).
Cell-free superoxide-generating system
NADPH oxidase activity was reconstituted through a
broken cell system (BCS). Briefly, neutrophil membranes
(30 μg) were mixed with cytosol (300 μg) in PBS buffer
containing 20 μM GTPγS, 5 mM MgCl2 and arachidonic
acid in a final volume of 100 μl. After incubation, the
oxidase was measured in the presence of 100 μM
cytochrome c with 150 μM NADPH (Cohen-Tanugi et
al. 1991).
In vitro cytosolic proteins p47phox and p67phox
translocation in a BCS
Translocation of cytosolic factors p47phox and p67phox to
the plasma membranes after in vitro NADPH oxidase
activation was performed following classical procedures
(Stasia et al. 2002).
In vivo p47phox translocation by confocal microscopy
analysis
Differentiated PLB-985 cells (106) in 10 mM HEPES
pH 7.4 (138 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4,
1.5 mM KH2PO4, 0.6 mM CaCl2, 1.0 mMMgCl2, 5.5 mM
glucose, and 0.5% (wt/vol) human albumin) deposited on
coverslips were activated for 10 min or 30 min with
serum-treated zymosan (STZ; 0.2 mg/ml) at 37°C. The
cells were washed with PBS, fixed and permeabilized with
methanol and incubated for 1 h at room temperature with a
mAb directed against p47phox (a generous gift from Dr.
Heyworth). The cells were then stained with Alexa-568-
labelled goat-anti-mouse-Ig antibodies (Molecular Probes,
Eugene, Ore., USA). After a 1-h incubation, the cells were
washed twice with PBS. The p47phox localization in STZ-
treated PLB-985 cells was examined with a Zeiss Axiovert
100 confocal laser-scanning microscope and analyzed with
LSM 5 software (Zeiss, Göttingen, Germany).
Ribbon diagram of the three-dimensional model of the
cytosolic part of gp91phox
With the program SwissPDB Viewer, a picture of the
three-dimensional (3D) model of gp91phox was made and
the residues His303 and Pro304 were highlighted (Taylor
et al. 1993; Guex and Peitsch 1997).
Protein determination
Protein content was estimated by using the Bradford assay
(Bradford 1976) or the Pierce method (Smith et al. 1985).
Results
Gp91phox expression in transgenic PLB-985 cells that
mimicked X+ CGD neutrophils
A high stable expression of recombinant His303Asn/
Pro304Arg, His303Asn and Pro304Arg gp91phox in X-
CGD PLB-985 cells was observed by flow cytometry after
staining with the 7D5 mAb recognizing an external
epitope of gp91phox (Fig. 1A). The specificity of the
7D5 binding was assessed with an irrelevant monoclonal
IgG1. Gp91phox expression was as high in the WT
gp91phox PLB-985 cells as in the double-mutant cells.
The level of recombinant His303Asn or Pro304Arg
gp91phox protein assessed by MFI values in Table 1
was slightly less than in the double-mutant transgenic
PLB-985 cells. In contrast, in X-CGD PLB-985 cells
transfected with the empty vector pEF-PGKneo, gp91phox
at the cellular membrane was undetectable. Nevertheless,
the high gp91phox expression in transgenic PLB-985 cells
was confirmed by semi-quantitative immunoblotting anal-
ysis. P22phox expression was higher in WT or mutated
gp91phox PLB-985 cells than in X-CGD PLB-985 cells
(Fig. 1B). Other clones containing the studied mutations
(ten clones for His303Asn gp91phox PLB-985 cells, ten
clones for Pro304Arg gp91phox PLB-985 cells, and six
clones for His303Asn/Pro304Arg gp91phox PLB-985
cells) were also tested for their expression of gp91phox.
Similar levels of mutated recombinant protein were
observed for each type of mutant cell (data not shown).
Reduced-minus-oxidized difference spectra were per-
formed in 1% Triton-X100 soluble extracts from transfec-
ted PLB-985 cells. Identical spectra characteristic of
flavocytochrome b558 were observed for both mutated
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and WT gp91phox PLB-985 cells and the amount of
cytochrome b558 correlated with the level of gp91phox
expression checked by flow cytometry (Table 1, Fig. 1C).
Thus, the expression of recombinant WT or mutated
gp91phox was efficient in transgenic PLB-985 cells and
the methods used, viz. flow cytometry, Western blot and
spectrophotometry, gave similar results for the quantifica-
tion of the level of gp91phox expression.
The NADPH oxidase activity in transfected X-CGD
PLB-985 cells
The functional analysis of WT gp91phox PLB-985 cells
was performed to check whether our tools and methodol-
ogy to restore oxidase activity were efficient (ex vivo
therapy). We first examined respiratory-burst oxidase
activity in intact transgenic PLB-985 cells expressing
recombinant WT gp91phox by means of the chemilumi-
nescence technique to measure H2O2 formation quantita-
tively after PMA stimulation. At least six different types of
clone for each studied mutation were tested for their
NADPH oxidase activity in intact cells, giving similar
results (data not shown). With granulocytic differentiation
in 0.5% DMF, H2O2 production from WT gp91phox PLB-
985 cells was comparable with the activity measured in the
original WT PLB-985 cells with a maximum at day 6
(Fig. 2). In His303Asn/Pro304Arg gp91phox PLB-985
cells, NADPH oxidase activity was totally abolished. The
His303Asn mutation was sufficient totally to inhibit the
respiratory burst of transgenic PLB-985 cells and the
inhibitory effect was independent of the time of differen-
tiation (Fig. 2). In the Pro304Arg gp91phox PLB-985
cells, very low NADPH oxidase activity was measured,
corresponding to about 4% of the activity found in control
WT gp91phox PLB-985 cells, as seen in the insert of
Fig. 2. Individually, both mutations had an inhibitory
effect on NADPH oxidase activity but the impact of the
His303Asn substitution was apparently more pronounced
than that of the Pro304Arg mutation in intact transgenic
PLB-985 cells.
The NADPH oxidase activity was then studied in an in
vitro O2 generating system (BCS) by using purified
plasma membranes from all transgenic PLB-985 cells. In
Fig. 1A–C Expression of recombinant WT and mutated gp91phox
in transgenic PLB-985 cells. A Transgenic PLB-985 cells (5×105)
were incubated with the gp91phox mAb 7D5, as described. Mouse
IgG1 isotype was used as an irrelevant mAb. B Immunodetection of
p22phox and gp91phox sub-units of cytochrome b558 was performed
with 50 μg 1% Triton-X100 soluble extracts subjected to SDS-
PAGE (10% acrylamide gel), blotted onto a nitrocellulose sheet and
revealed with mAbs 449 and 48. C Cytochrome b558 differential
spectra of transgenic PLB-985 cells were conducted with the same
soluble extract of transgenic PLB-985 cells as described in B.
Results are from one representative from triplicate analyses
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order to compare only the effect of mutations on gp91phox
in the plasma membranes, cytosol from purified human
neutrophils was used as a source of cytosolic NADPH
oxidase components. The in vitro oxidase activity in WT
gp91phox PLB-985 cells was nearly identical to that of the
WT PLB-985 cells (Table 1). Residual NADPH oxidase
activity was measured in the double-mutant cells and in
the His303Asn gp91phox PLB-985 cells (24% and 22% of
the WT PLB-985 cell activity, respectively). In contrast,
Pro304Arg gp91phox PLB-985 cells exhibited about 60%
of the WT gp91phox PLB-985 cells reconstituted oxidase
activity. This confirmed that the Pro304Arg mutation had
less effect on NADPH oxidase activity than the
His303Asn substitution and that the amount of Pro304Arg
gp91phox was sufficient to reconstitute a part of the
NADPH oxidase activity in a BCS.
Study of the assembly of the NADPH oxidase
complex in transgenic PLB-985 cells
In a previous publication, we demonstrated that the
His303Asn/Pro304Arg mutation of the gp91phox protein
in neutrophils of a X+ CGD patient inhibit the in vitro
translocation of the cytosolic factors p47phox and
p67phox to the plasma membrane disturbing the
NADPH oxidase assembly (Stasia et al. 2002). Here, the
aim was to determine whether the inhibitory effect of each
Table 1 Phenotypic characterization of transgenic PLB-985 cells.
(MFI mean fluorescence intensity in au). Haem content was
quantified by the Soret absorption of 1% Triton-X100 soluble
extract from transgenic cells, considering that cytochrome b558
contains two haems. H2O2 production was measured by chemilu-
minescence from 5×105 intact transgenic PLB-985 cells differen-
tiated with 0.5% DMF for 6 days and stimulated with 80 ng/ml
PMA. Relative luminescence unit (RLU) represents the sum of RLU
measured over 1.5 h. NADPH oxidase activity was reconstituted in a
CFS assay with purified plasma membranes of the indicated cells
(30 μg) in the presence of neutrophil cytosol (300 μg) and activated
with GTPγS and arachidonic acid.O2 was measured by the SOD-
sensitive cytochrome c reduction assay. Values in the table represent
the mean ± SD of triplicate determinations
Transgenic
PLB-985 cells
Gp91phox
expression
MFI (au)
Cytochrome
b558 pmol/mg
proteins
H2O2
production
RLU
Percentage of
control
O2 production
in a BCS assay
(nmol/min/mg) protein
Percentage of control
X-CGD PLB-985 cells 3 0 0.6±0.1 0 7.1±3.8 4
Empty vector 3 0 0.5±0.1 0 10.7±5.0 6
His303Asn gp91phox 32 10.4±2.4 0.6±0.1 0 37.8±15.3 22
Pro304Arg gp91phox 49 14.2±0.2 17.7±4.7 4 115.3±17.9 67
His303/Pro304 gp91phox 84 24.2±0.5 0.5±0.1 0 41.7±28.9 24
WTgp91phox 90 21.8±0.7 362.4±15.5 99 147.7±11.9 86
WT PLB-985 cells (control) 95 26.3±3.0 364.9±10.6 100 170.8±3.4 100
Fig. 2 NADPH oxidase activity
in whole transgenic PLB-985
cells during the time course of
differentiation. The indicated
cells were induced for granulo-
cytic differentiation with 0.5%
DMF. H2O2 production by
whole intact cells was measured
on days 5, 6, and 7 by chemi-
luminescence by using luminol
in the presence of peroxidase.
Insert Magnification of some
results from Fig. 2. Results
represent the mean ± SD of
triplicate determinations
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single mutation and the double mutation on NADPH
oxidase activity was related to a defect of its assembly in
vitro and in vivo. As seen in Fig. 3A, in WT gp91phox
PLB-985 cells, the translocation of p47phox and p67phox
to the plasma membranes occurs normally as observed for
WT PLB-985 cells and for human control neutrophils. In
addition, as we had previously observed in neutrophils of
the X+ CGD patient, no translocation of the cytosolic
factors was detected when the plasma membranes
originated from the His303Asn/Pro304Arg gp91phox
PLB-985 cells. For the single mutation, a faint cytosolic
factor translocation was shown (more visible for p47phox)
but the defect of translocation was more pronounced for
the His303Asn than for the Pro304Arg mutation. No in
vitro cytosolic factor translocation to the plasma mem-
brane was visible after SDS and GTPγS stimulation in the
X-CGD PLB-985 cells transfected with the empty vector
(data not shown) or in human neutrophils from an X0
CGD patient (Fig. 3A). This confirmed that, in the absence
of cytochrome b558, no translocation of p67phox and
p47phox could occur.
Then the in vivo p47phox translocation was checked in
WT, X-CGD and transgenic PLB-985 cells differentiated
for 6 days with 0.5% DMF and stimulated in the presence
of STZ for 10 or 30 min at 37°C. The assembly of the
oxidase complex was evaluated by confocal microscopy to
follow the p47phox translocation to the phagosomal
membranes (Fig. 3B). Undisturbed phagocytosis of STZ
was checked by phase contrast microscopy. In the original
X-CGD PLB-985 cells transfected with the empty vector
pEF-PGKneo, phagocytosis of STZ occurred even in the
absence of gp91phox and NADPH oxydase activity but
Fig. 3A, B Study of the NADPH oxidase assembly in transgenic
PLB-985 cells. A NADPH oxidase was activated in vitro in the
presence (+) or absence (−) of SDS and GTPγS in human neutrophil
cytosol, by using purified membrane fractions from transgenic PLB-
985 cells, human control neutrophils and neutrophils from a X0
CGD patient. p47phox and p67phox were detected in plasma
membranes by Western blot after purification in a discontinuous
sucrose gradient. This result represents one experiment of three. B In
vivo p47phox translocation was followed in STZ-activated trans-
genic PLB-985 cells by confocal microscopy analysis. A total of 106
WT PLB-985 cells or X-CGD PLB-985 cells or the indicated
transgenic PLB-985 cells were stimulated with STZ for 10 min on
day 6 after DMF differentiation
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p47phox was uniformly distributed in the cytosol indicat-
ing that there was no translocation to the membrane of the
phagosome. In contrast, in WT gp91phox PLB-985 cells,
p47phox translocation occurred, as a strong red fluores-
cence was seen surrounding the STZ particles. On the
contrary, no p47phox translocation was observed in the
double-mutant gp91phox PLB-985 cells or in His303Asn
gp91phox PLB-985 cells. However, in Pro304Arg
gp91phox PLB-985 cells, the p47phox translocation
occurred but with a seemingly lower efficiency than in
WT 91 phox PLB-985 cells. The same results were
obtained in a second set of experiments in which the
incubation time of transgenic PLB-985 cells with STZ was
30 min instead of 10 min (data not shown). We concluded
that the double-mutated gp91phox PLB-985 cells exactly
mimicked the phenotype of the X+ CGD neutrophils
previously described. The absence of NADPH oxidase
activity was thus related to a defect in oxidase component
assembly during in vitro and in vivo activation. The single
mutation His303Asn also induced the inhibition of this
assembly, whereas Pro304Arg had a weak effect upon it
related to the remaining oxidase activity measured in
Pro304Arg mutant PLB-985 cells.
The functional significance of the His303Asn and
Pro304Arg mutation was further analysed in a 3D-model
of the C-terminal tail of gp91phox (Taylor et al. 1993;
Leusen et al. 2000). This model shows that both His303
and Pro304 are located at the surface of the protein, at the
N-terminal of the beta-sheet (βF2) in hydrophilic
surroundings (Fig. 4). The charge changes induced by
the mutations (His303Asn, more neutral; Pro304Arg,
strongly positive) will therefore not strongly affect the
positions of the surrounding residues. Moreover, His303
and Pro304 do not form strong hydrogen bonds with
nearby amino acids and do not directly interact with FAD
or NADPH (the distance is minimally 6–7 Å).
Discussion
The neutrophil respiratory-burst dysfunction resulting
from an X+ CGD double-missense mutation was recently
reported (Stasia et al. 2002). Here, transgenic X-CGD
PLB-985 cells have been used to investigate the impact of
His303Asn and/or Pro304Arg mutations and to correlate
these mutations with NADPH oxidase assembly and
activity. This approach has also been effective in ruling
out the possibility of a new polymorphism in the CYBB
gene.
Cell therapy strategy in X-CGD PLB-985 cells
The first step of our approach was to validate our
methodology and tools for restoring NADPH oxidase
activity in the X-CGD PLB-985 cells transfected with the
WT gp91phox cDNA (ex vivo therapy; Zhen et al. 1993;
Yu et al. 1999). A high level of WT recombinant
gp91phox protein appeared to be correctly processed and
targeted to the plasma membrane (Fig. 1A), because the
7D5 monoclonal Ab recognized an external epitope of
gp91phox (Yamauchi et al. 2001). There was a good
correlation between the level of gp91phox expression in
transgenic WT gp91phox PLB-985 cells checked by flow
cytometry, Western blot analysis and differential spectro-
photometry (Table 1, Fig. 1A–C). The last-mentioned
method demonstrated normal haem group incorporation in
the recombinant gp91phox protein. An increase in
p22phox expression in transgenic PLB-985 cells versus
X-CGD PLB-985 cells was consistent with previous
observations, indicating that the co-expression of both
sub-units of cytochrome b558 and heterodimer synthesis
was essential for the stable expression of the haemoprotein
(DeLeo et al. 2001). NADPH oxidase activity in WT
gp91phox PLB-985 cells was restored in a similar range to
that originally measured in differentiated WT PLB-985
cells (Fig. 2, Table 1). All these results established that the
cultured myeloid PLB-985 cell line genetically deficient in
gp91phox was a useful tool for expressing recombinant
gp91phox for functional analysis, as previously described
in a similar approach (Yu et al. 1999).
The second step was to investigate the phenotype of the
X+ CGD mutations (His303Asn/Pro304Arg) after trans-
fection of each mutated cDNA or both in X-CGD PLB-
985 cells. As shown in Table 1 and Fig. 1, lower levels of
cytochrome b558 were detected in single mutated
gp91phox PLB-985 cells than in the double-mutant cells,
whereas recombinant mutated gp91phox proteins were
correctly processed. This was observed in other tested
clones for each type of mutation. Possibly, the double
mutation provided greater translation efficiency than did
the single mutation. This was shown previously, the
authors demonstrating that the functional correction of X-
CGD neutrophils did not require a high level of gp91phox
(Zhen et al. 1993). The double mutation His303Asn/
Pro304Arg led to total inhibition of the oxidase activity in
whole transgenic PLB-985 cells, independently of the
Fig. 4 Ribbon diagram of the 3D-model of the cytosolic C-terminal
tail of gp91phox with the specific residues His303 and Pro 304
located in the ribbon structure. The α-helices are depicted as
cylinders and the β-sheets as arrows. His303 and Pro304 are
indicated in pink, the FAD cofactor in yellow and the coenzyme
NADPH in purple
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differentiation day (Fig. 2). Surprisingly, the His303Asn
substitution was sufficient to abolish NADPH oxidase
activity entirely, although residual activity was measured
with the second mutation Pro304Arg. After oxidase
reconstitution in the BCS, the His303Asn mutation had
the same inhibitory effect on oxidase activity as the double
mutation (Table 1), whereas Pro304Arg gp91phox PLB-
985 cells showed roughly 60% of the reconstituted oxidase
activity of WT gp91phox PLB-985 cells. The Pro304Arg
mutation had a lower effect on NADPH oxidase activity in
intact cells and particularly in BCS than did the
His303Asn mutation; artificial NADPH oxidase assembly
in vitro is probably not completely comparable to that in
vivo. For example, NADPH oxidase activity can be
reconstituted in vitro in the absence of p47phox and in the
presence of a large amount of p67phox (Paclet et al. 2000).
The arachidonic acid may change the conformation of
proteins and force cytosolic factor interactions within
cytochrome b558. In contrast, in AR47
0 CGD cases with
the absence of p47phox, no oxidase activity can be
measured in the neutrophils of the patients.
In a previous article characterizing the studied double-
missense mutation in two first cousins suffering from an
X+ CGD (Stasia et al. 2002), no double or single mutations
were found in genomic DNA purified from 50 healthy
donors (50% were women). We conclude that the
phenotype of the His303Asn/Pro304Arg gp91phox PLB-
985 cells exactly mimics that of the neutrophils of the X+
CGD patient and that neither mutation can be considered
as a polymorphism in the CYBB gene.
Only one polymorphism has been described in the
CYBB gene (G1102C); this predicts a Gly364Arg substi-
tution that neither affects NADPH oxidase activity nor
gp91phox expression (Kuribayashi et al. 1996). Thus, the
CYBB gene appears to be highly sensitive to mutations.
Another striking point is that a double-missense mutation
is a rare event in human diseases. Generally, a single base
change is sufficient to induce a genetic illness. For
example, in cystic fibrosis, which is the most common
genetic disease, no double-missense mutations have been
found in the 532 reported cases in the human gene
mutation database (Stenson et al. 2003). In addition, the
reported double-mutation cases often involve two mis-
sense mutations localized in the same allele but not close
to each other (Yamamoto et al. 1998; Saad et al. 1998). In
CGD disease, only one case of a double-missense
mutation has been reported in the NCF2 gene, the patient
being heterozygous for each mutation according to
genomic DNA analysis (Bonizzato et al. 1997). However,
a double-missense mutation D2625E/A2626P has been
found in the ATM protein of a Dutch family with ataxia
telangiectasia (Van Belzen et al. 1998); this results in a
change in the secondary structure of the mutated ATM
protein (the effect of each single mutation was not
studied). To our knowledge, our study is the first to report
a double-missense mutation in a human genetic disease in
detail following the use of direct mutagenesis and
transfection experiments in a human cell line.
A number of single nucleotide substitution mechanisms
have been identified (Cooper and Krawczak 1990). The
best known is point mutation via methylation-mediated
deamination, CG dinucleotides indeed being hotspots of
mutation causing human genetic diseases. The C-to-A and
C-to-G substitutions found in our case have not frequently
been described and may be caused by polymerase-
mediated misincorporation of bases during DNA replica-
tion, perhaps by a mechanism involving transient base
misalignment. The probability that both missense muta-
tions occurred at the same time is very weak. Interestingly,
Pro304 is highly preserved in gp91phox analogues in
plants (Torres et al. 1998) and in microorganisms
(Lalucque and Silar 2003), whereas His303 and Pro304
appear in Dictyostelium Discoideum (Genbank accession
no. AY221173). His303 and Pro304 seem to play an
important role in the NAD(P)H oxidase activity in
eukaryotic cells because they are preserved in all Nox
analogues except His 303 in Nox 5 (Cheng et al. 2001).
NADPH oxidase assembly
The 3D-model of the C-terminal tail of gp91phox (Fig. 4)
highlights the localization of His303 and Pro304 at the
surface of gp91phox and indicates that the distance to the
FAD-binding site is not compatible with a direct interac-
tion of these amino acids with the binding site. This
confirms our previous result that FAD binding is not
affected by the double mutation (Stasia et al. 2002). We
show in the present paper, both in vitro and in vivo, that
both His303Asn and Pro304Arg mutations, separately and
together, are correlated with the dysfunction of cytosolic
factor translocation. Moreover, the level of resulting
oxidase activity is proportional to the extent of transloca-
tion efficiency (Fig. 3, Table 1). The strongest effect on the
structure of the protein might be expected from the
Pro304Arg mutation, because this affects the backbone of
the loop between βF1 and βF2 and might have an effect
on the binding sites for p47phox and p67phox, probably
located at the surface of the protein. Nevertheless, the net
charge of this loop region is probably important for
p47phox binding and NADPH oxidase activity.
The main conclusion of the present work is the
validation of the X+ CGD transgenic PLB-985 cellular
model for efficiently studying the functional consequences
of the double and single mutations His303/Pro304 on
NADPH oxidase activation and assembly. Double-mutated
gp91phox transgenic PLB-985 cells exactly mimic the
phenotype of the X+ CGD neutrophils previously
described, in which the absence of NADPH oxidase
activity is related to a defect in oxidase complex assembly.
Our results also suggest that the His303Asn mutation is
sufficient to prevent NADPH oxidase activity and
assembly, whereas the Pro304Arg substitution has less
effect on it, but neither mutation can be considered as a
polymorphism.
Nevertheless, we have not established that His303 and
Pro304 directly bind p47phox and/or p67phox. The
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mutations may lead to a conformational change in
cytochrome b558 disturbing cytosolic factor assembly.
The conformational change in mutated cytochrome b558
and its direct interaction with cytosolic factors are
currently under investigation in our laboratory by atomic
force microscopy (Paclet et al. 2000) with a simplified
activation system including purified mutated cytochrome
b558 and recombinant p47phox and/or p67phox proteins.
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